ArticleCancer chemotherapy and pharmacology2022

Safety of immune checkpoint inhibitors in non-small-cell lung cancer patients with idiopathic interstitial pneumonia: a matched case-control study.

Takenori Ichimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.